Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 4, 1996, Pages 251-267

  Pilger, Ernst ^a   Eriksson, Henry ^b   Grüngreiff, Kurt ^c   Carlsson, Anders ^d   Talstad, Ingebrigt ^e   Anders, Olaf ^f   Schuchardt, Christa ^g   Munck, Denis ^h   Lafer, Marianne ^a  

^a Medizinische Universität Klinik   (Austria)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Private Practice   (Germany)

^d DANDERYD HOSPITAL   (Sweden)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g HELIOS KLINIKUM BERLIN BUCH   (Germany)

^h Chirugie Vasculaire   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; WARFARIN;

ALLERGIC REACTION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; FEMORAL VEIN; HUMAN; HYPOTENSION; ILIAC VEIN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHLEBOGRAPHY; POPLITEAL VEIN; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RASH;

EID: 0029967218     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80033-6     Document Type: Article

References (24)

1. Francis CW, Marder VJ. Fibrinolytic therapy for venous thrombosis. Prog Cardiovasc Dis. 1991;34:193-204.
2. Coon WW, Willis PW, Keller JB. Thromboembolism and other venous diseases in the Teunsech community health study. Circulation. 1973;48:839-846.
3. Levine MNB, Raskob G, Hirsh J. Haemorrhagic complications of long term anticoagulant therapy. Chest. 1989;95(Suppl):26S-36S.
4. Rogers LQ, Lutcher CL. Streptokinase therapy for deep vein thrombosis: A comprehensive review of the English literature. Am J Med. 1990;88:389-395.
5. Goldhaber SZ, Kessler CM, Heit JA, et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: A randomized controlled multicenter trial. J Am Coll Cardiol. 1992;20:24-30.
6. Gruppo Italiano per lo Studio Della Streptochinasi Nell infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
7. Theiss W, Bauman G, Klein G. Fibrinolytische Behandlung tiefer Venenthrombosen mit Streptokinase in ultrahoher Dosierung. Dtsch Med Wochenschr. 1987;112:668-674.
8. Martin M, Othmar Fiebach BJ. Short-term ultra high streptokinase treatment of chronic arterial occlusions and acute deep vein thrombosis. Semin Thromb Hemost. 1991;17:21-38.
9. Marder VJ, Soulen RL, Atichartakarn V, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med. 1977;89:1018-1029.
10. Lehmann EL. Nonparametrics. San Francisco: Holden Day; 1975.
11. Schulman S, Lockner D, Granqvist S, et al. A comparative randomized trial of low-dose versus high-dose streptokinase in deep vein thrombosis of the thigh. Thromb Haemost. 1984;51:261-265.
12. Sherry S, Bell WR, Duckert H, et al. Thrombolytic therapy in thrombosis: A National Institutes of Health Consensus Development Conference. Ann Intern Med. 1980;93:141-144.
13. Messner AJ, Misiak A, Ziemski JM, et al. Hazards of thrombolytic therapy in deep venous thrombosis. Br J Surg. 1987;74:991-993.
14. Fahn H, Maubach P, Merkl R, et al. Ultrahochosierung Thrombolysetherapie mit Streptokinase bei periphereal Thrombose. Med Klin. 1989;84:183-187.
15. Holmström M, Bralte G, Törnebohm A, et al. Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg? J Int Med. 1990;228:647-649.
16. Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardial infarction (TIMI) trial - phase I. Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 1988;11:1-11.
17. Meyerovitz MF, Polak JF, Goldhaber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: Predictive value of venographic appearance. Radiology. 1992; 184:345-348.
18. Théry C, Bauchart JJ, Lesenne M, et al. Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol. 1992;69:117-122.
19. Francis CW, Marder VJ. Increased resistance to plasmic degradation of fibrin with highly crosslinked x polymer chains formed at high factor XIII concentrations. Blood. 1988;71: 1361-1365.
20. Marder VJ, Soulen RL, Atichartakan V, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med. 1977;89:1018-1029.
21. Astedt B, Robertson B, Haeger K. Experience with standardized streptokinase therapy of deep venous thrombosis. Surg Gynecol Obstet. 1974;139:387-388.
22. Theiss W, Wirtzfeld A, Fink U, Maubach P. The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins. Angiology. 1983;34:61-69.
23. Duckert F, Müller G, Nyman D, et al. Treatment of deep vein thrombosis with streptokinase. Br Med J. 1975;1:479-481.
24. Bonnet J, Colle JP, Lorient-Roudaut MF, et al. Efficacite et interet des fibrinolytiques dans les thromboses veineuses anciennes proximales des membres inferieurs. Arch Mal Coeur. 1984;77:1033-1038.